In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone: Commentary

Amy T. Wang; Steven A. Smith

doi:10.7326/0003-4819-153-12-201012210-02011

In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone: Commentary

Amy T. Wang, Steven A. Smith

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	JC6-11
Journal	Annals of internal medicine
Volume	153
Issue number	12
DOIs	https://doi.org/10.7326/0003-4819-153-12-201012210-02011
State	Published - Dec 21 2010

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/0003-4819-153-12-201012210-02011

Cite this

@article{09a488fe9c0c4df9a3a483959959120e,

title = "In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone: Commentary",

author = "Wang, {Amy T.} and Smith, {Steven A.}",

year = "2010",

month = dec,

day = "21",

doi = "10.7326/0003-4819-153-12-201012210-02011",

language = "English (US)",

volume = "153",

pages = "JC6--11",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "12",

}

TY - JOUR

T1 - In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone

T2 - Commentary

AU - Wang, Amy T.

AU - Smith, Steven A.

PY - 2010/12/21

Y1 - 2010/12/21

UR - http://www.scopus.com/inward/record.url?scp=78751627542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751627542&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-153-12-201012210-02011

DO - 10.7326/0003-4819-153-12-201012210-02011

M3 - Comment/debate

AN - SCOPUS:78751627542

SN - 0003-4819

VL - 153

SP - JC6-11

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 12

ER -

In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone: Commentary

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this